ArticleThe Biochemical journal2021

Simultaneous targeting of CD44 and MMP9 catalytic and hemopexin domains as a therapeutic strategy.

Gal Yosef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.